T2 Biosystems, Inc. provided preliminary unaudited revenue guidance for fourth quarter and full Year 2020. For the quarter, the company expected revenue to be $7.8 million, representing growth of 155% and 274% respectively, compared to the prior year period. For the year, the company expected revenue to be $18.1 million, representing growth of 118% and 119% respectively, compared to the prior year period.